Skip to main content
. 2021 Jan 29;115:e200520. doi: 10.1590/0074-02760200520

TABLE III. TB-profiler versus MTBSEQ whole-genome sequencing tools according to Kappa Coefficient.

Kappa (Interpretation) Observed concordance Replicability 95% CI p-value
Drugs TB-profiler MTBSEQ TB-profiler MTBSEQ TB-profiler MTBSEQ TB-profiler MTBSEQ TB-profiler MTBSEQ
INH 0.854 0.692 92.96% 84.51% Almost perfect Substantial 0.731 to 0.977 0.528 to 0.856 <0.0001 <0.0001
RIF 0.792 0.713 91.55% 88.73% Substantial Substantial 0.635 to 0.949 0.528 to 0.898 <0.0001 <0.0001
PZA 0.508 0.238 92.96% 87.32% Moderate Fair 0.133 to 0.882 -0.108 to 0.585 <0.0001 <0,0219
EMB 0.645 0.653 90.41% 91.55% Substantial Substantial 0.411 to 0.879 0.400 to 0.906 <0.0001 <0.0001
SM 0.776 0.718 95.77% 94.73% Substantial Substantial 0.533 to 1.000 0.457 to 0.980 <0.0001 <0.0001

INH: isoniazid; RIF: rifampicin; PZA: pyrazinamide; EMB: ethambutol; SM: streptomycin; 95% CI: 95% confidence interval.